| 摘要 |
<p>The present invention provides a population of functional haematopoeitic cells. The cells have a CD34+ phenotype and further express a lectin. These cells may be used to lower the risk of graft versus host disease, generate monoclonal antibodies and in bone marrow transplants.</p> |
